Alpha Tau Medical Ltd. DRTS
We take great care to ensure that the data presented and summarized in this overview for Alpha Tau Medical Ltd. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DRTS
View all-
Levin Capital Strategies, L.P. New York, NY307KShares$955,7800.07% of portfolio
-
Hoyle Cohen, LLC269KShares$836,8630.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$717,4890.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$206,2730.01% of portfolio
-
Satovsky Asset Management LLC53.6KShares$166,7140.03% of portfolio
-
Private Advisor Group, LLC47.6KShares$147,9830.0% of portfolio
-
Morgan Stanley New York, NY43.3KShares$134,7900.0% of portfolio
-
Mariner, LLC Overland Park, KS40.8KShares$126,7350.0% of portfolio
-
Geode Capital Management, LLC Boston, MA35.7KShares$111,0760.0% of portfolio
-
Kovitz Investment Group Partners, LLC32.3KShares$100,3440.0% of portfolio
Latest Institutional Activity in DRTS
Top Purchases
Top Sells
About DRTS
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
Insider Transactions at DRTS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|